Adaptive Biotechnologies Corp (ADPT) — Capital Reinvestment Ratio

Latest as of March 2019: 0.01x

Adaptive Biotechnologies Corp (ADPT) has a Capital Reinvestment Ratio of 0.01x as of March 2019, meaning it reinvests 0% of its operating cash flow ($278.30 Million) in capital expenditures ($3.83 Million). See Adaptive Biotechnologies Corp balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$278.30 Million
USD

Capital Expenditures

$3.83 Million
USD

Data as of

Mar 2019
Most recent filing

Adaptive Biotechnologies Corp Capital Reinvestment Ratio (2019–2019)

This chart tracks Adaptive Biotechnologies Corp's Capital Reinvestment Ratio across 1 annual periods. Check Adaptive Biotechnologies Corp (ADPT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Adaptive Biotechnologies Corp (2019–2019)

Year-by-year Capital Reinvestment Ratio for Adaptive Biotechnologies Corp from 2019 to 2019. For live market cap and broader valuation context, see ADPT market cap overview.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.05x $205.40 Million $11.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow